Psychopharmacology Exam #2 - Drug-Induced Movement Disorder

Beschreibung

Quiz am Psychopharmacology Exam #2 - Drug-Induced Movement Disorder, erstellt von Melanie Grynsztejn am 23/03/2018.
Melanie Grynsztejn
Quiz von Melanie Grynsztejn, aktualisiert more than 1 year ago
Melanie Grynsztejn
Erstellt von Melanie Grynsztejn vor mehr als 6 Jahre
49
1

Zusammenfassung der Ressource

Frage 1

Frage
The following are early onset EPS symptoms
Antworten
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskensia

Frage 2

Frage
Which EPS symtom can appear within days
Antworten
  • Dystonia
  • Akatsia
  • Parkinsonism
  • Tardive dyskinesia

Frage 3

Frage
Which EPS symptom can appear within weeks?
Antworten
  • Dystonia
  • Akathisia
  • Parkinsonsism
  • Tardive dyskenia

Frage 4

Frage
Which EPS symptom can appear within months?
Antworten
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskinesia

Frage 5

Frage
Which EPS symtoms can take years to appear?
Antworten
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskensia

Frage 6

Frage
Types of drug-induced movement disorders: [blank_start]Acute:[blank_end] Occur within a short duration of treatment onset or dose increase [blank_start]Chronic:[blank_end] Symptoms persist throughout treatment [blank_start]Tardive[blank_end]: Delayed onset of symptoms [blank_start]Withdrawal:[blank_end] Occur in the absence of treatment. May resolve
Antworten
  • Acute:
  • Withdrawal:
  • Chronic:
  • Tardive
  • Tardive
  • Withdrawal
  • Withdrawal:
  • Tardive

Frage 7

Frage
Dopamine system pathways include: Mesolimbic: arousal, memory, behavior Mesocortical: cognition, socializaiont Tuberoinfundibular: regulation of prolactin Nigrostriatal: modulation of EPS
Antworten
  • True
  • False

Frage 8

Frage
The mechanism for dystonia is
Antworten
  • Dopamine deficiency in the basal ganglia and striatum
  • Overactive cholinergic system
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens
  • Blockade of the striatal dopamine receptors

Frage 9

Frage
What are risk factors for dystonia
Antworten
  • Young age
  • H/O ECT
  • Male gender
  • High potency neuroleptics - Haldol, Prolixin
  • Comorbid medical conditions

Frage 10

Frage
Types of dystonia
Antworten
  • Opisthotonos
  • Blepharospasm
  • Torticollis
  • Oculogyric crisis
  • Oro-mandibular

Frage 11

Frage
The MOA for akathisia, from the Greek meaning "inability to sit", is:
Antworten
  • Dopamine deficiency in the basal ganglia and striatum
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens, Overstimulation of locus coeruleus.
  • Blockade of the striatal dopamine receptors
  • Striatal dopaminergic hypersensitivity

Frage 12

Frage
Which of the following agents cause akathisia
Antworten
  • SSRI
  • Second generation antipsychotics
  • Antiemetics
  • CCB
  • Anti-anxiolytics

Frage 13

Frage
What are some differentials for akathisia
Antworten
  • GAD
  • ADHD
  • Agitation
  • MDD

Frage 14

Frage
What are clinical presentation of akathisia
Antworten
  • Restlessness
  • Breaking out into song & dance for no reason
  • Fidgety movements/leg swinging
  • Marching in place
  • Rocking from one foot to another
  • Picking

Frage 15

Frage
The risk factors for akathisia include
Antworten
  • Advanced age
  • Affective disorder
  • Cognitive impairment
  • Female impersonator performer
  • Female
  • H/O akathisia
  • Iron deficiency
  • High dose/potency/neuroleptics

Frage 16

Frage
Pathophysiology of pseudoparkinsonism is:
Antworten
  • Dopamine deficiency in the basal ganglia and striatum
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens
  • Blockade of the striatal dopamine receptors and depletion of pre-synaptic celft
  • Striatal dopaminergic hypersensitivity and cholinergic deficiency in the basal ganglia

Frage 17

Frage
Parkinsonism = [blank_start]bradykesia[blank_end] Pseudoparkinsonism = [blank_start]apraxic slowness[blank_end]
Antworten
  • bradykesia
  • apraxic slowness
  • bradykinesia
  • apraxic slowness

Frage 18

Frage
Parkinsonism = [blank_start]resting tremor[blank_end] Pseudoparkinsonism = [blank_start]essential tremor, myoclonus[blank_end]
Antworten
  • resting tremor
  • essential tremor, myoclonus
  • resting tremor
  • essential tremor, myoclonus

Frage 19

Frage
Parkinsonism = [blank_start]lead pipe rigidity[blank_end] Pseudoparkinsonism = [blank_start]paratonic rigidity[blank_end]
Antworten
  • lead pipe rigidity
  • paratonic rigidity
  • lead pipe rigidity
  • paratonic rigidity

Frage 20

Frage
Parkinsonism = [blank_start]postural instability[blank_end] Pseudoparkinsonism = [blank_start]frontal ataxia[blank_end]
Antworten
  • postural instability
  • frontal ataxia
  • postural instability
  • frontal ataxia

Frage 21

Frage
Parkinsonism = [blank_start]Slow, shuffling gait with festination[blank_end] Pseudoparkinsonism = [blank_start]Slow, shuffling apraxic gait[blank_end]
Antworten
  • Slow, shuffling gait with festination
  • Slow, shuffling apraxic gait
  • Slow, shuffling gait with festination
  • Slow, shuffling apraxic gait

Frage 22

Frage
What are risk factors for pseudoparkinsonism?
Antworten
  • Female
  • Male
  • Advanced age
  • Central DA receptor binding agents, Metclopramide, phenothiazines
  • AIDS
  • Cancer

Frage 23

Frage
Tardive dyskinesia
Antworten
  • If identified early can be reversed
  • is not reversible
  • increased risk with increased use
  • increased use does not cause increases risk
  • early onset
  • late onset

Frage 24

Frage
MOA for tardive dyskinesia
Antworten
  • Striatal dopaminergic hypersensitivity
  • Cholinergic deficiency within basal ganglia
  • Oxidative stress and cell injur
  • Genetic susceptibility
  • Glutamate-induced excitotoxicity
  • GABA mediated neuronal dysfunction
  • Blockade of the striatal dopamine receptors

Frage 25

Frage
Which medications most commonly cause tardive dyskinesia?
Antworten
  • Meoclopramide
  • Alpha adrenergic agonists
  • SGA
  • FGA

Frage 26

Frage
Clinical presention of tardive dyskinesia
Antworten
  • Choreiform - characterized by jerky, involuntary movements, chiefly of the face and extremities
  • Athetoid - characterized by slow, involuntary, convoluted, writhing movements of the fingers, hands, toes, and feet and in some cases, arms, legs, neck and tongue
  • Stereotypic - petitive, nonfunctional motor behavior (e.g., hand waving or head banging), that markedly interferes with normal activities or results in bodily injury.

Frage 27

Frage
EPS can be caused by antiemetics, antieliptics, psychotropics, cardiovascular agents and Levodopa
Antworten
  • True
  • False

Frage 28

Frage
EPS can be caused by antiemetics, antieliptics, psychotropics, cardiovascular agents and Levodopa
Antworten
  • True
  • False

Frage 29

Frage
The following drugs cause all four movement disorders: dystonia, akathisia, Parkinsonism, tardive dyskinesia
Antworten
  • Metoclopramide
  • Prochloraperazine
  • Amoxapine
  • Neuroleptics
  • SSRI
  • Levodopa

Frage 30

Frage
How often should the Abnormal Involuntary Movement Scale (AIMS) be administered?
Antworten
  • Baseline then every week x4 then every 3 months
  • Baseline then every week x2 then every 12 months
  • Baseline then every week x2 then every 6 months

Frage 31

Frage
What are overall tips for treatment of EPS?
Antworten
  • Stop offending agen (if possible)
  • Reduce the dose
  • Switch to a second generation antipsychotic
  • Treat prophylactically
  • A wing and prayer and refer to anyone else

Frage 32

Frage
Dystonia put in order of line of treatment First line = [blank_start]anticholinergic agents[blank_end] Second line = [blank_start]Baclofen[blank_end] Third line = [blank_start]Benzo[blank_end] Fourth line - [blank_start]Botox[blank_end]
Antworten
  • anticholinergic agents
  • Baclofen
  • Benzo
  • Botox

Frage 33

Frage
This is a nice visual/review
Antworten
  • True
  • False

Frage 34

Frage
Drug of choice for dystonia is
Antworten
  • Beta-blockers, anticholinergics, benzodiazepines, 5-HT2A receptor antagonist, mirtazapine
  • Anticholinergics (benztropine, diphenhydramine, trihexyphenidyl)
  • Clonzaepam, ginkgo biloba

Frage 35

Frage
Drugs of choice for akathisia include
Antworten
  • Anticholinergics (benztropine, diphenhydramine, trihexyphenidyl)
  • Beta-blockers, benzodiazepines, 5-HT2A receptor antagonist, mirtazapine
  • Clonazepam, ginkgo biloba

Frage 36

Frage
Mirtazapine (Remeron)
Antworten
  • Used in low doses to treat akathisa
  • Used in low doses to treat dystonia
  • Alpha-adrenergic receptor antagonist
  • Alpha-adrenergic receptor agonist
  • Antagonizes 5-HT2 and 3 receptors

Frage 37

Frage
Visual for treatment of akathisia
Antworten
  • True
  • False

Frage 38

Frage
Which drugs are used to treat pseudoparkinsonism?
Antworten
  • Cogentin (benztropine)
  • Symmetrel (amantadine)
  • Benzodiazepines
  • Mirtazapine (Remeron)
  • Diphenhydramine (Benadryl)

Frage 39

Frage
MOA for amantadine (Symmetrel) is
Antworten
  • Dopamine agonist
  • Dopamine antagonist
  • 5-HT2 agonist
  • 5-HT2 antagonist

Frage 40

Frage
Side effects for benztropine (Cogentin) include
Antworten
  • Dry mouth
  • Hypotension
  • Diarrhea
  • Constipation
  • Cognitive impairment
  • Sialorrhea

Frage 41

Frage
Side effects for amantadine (Symmetrel) include:
Antworten
  • Hypotension
  • Hypertension
  • Agitation
  • Sedation
  • Worsening s/s of psychosis

Frage 42

Frage
Which drugs are used in the treatment of tardive dyskinesia
Antworten
  • Diltiazem
  • Baclofen
  • Galantamine
  • Clonazepam
  • Ginkgo biloba

Frage 43

Frage
What is the first FDA approved medication for Tardive Dyskinesia
Antworten
  • Velbeazine (Ingrezza)
  • Benztropine (Cogentin)
  • Trihexphenidyl (Artane)
  • Amantadine (Symmetrel)

Frage 44

Frage
What is the MOA for valbenazine (Ingrezza)?
Antworten
  • Blocks alpha-adrenergic receptors and antagonizes 5-HT2 and 3 receptors
  • Reversible inhibition of vesicular monoamine transporter 2 (VMAT2), a transporter that regulates monoamine uptake from the cytoplasm to the synaptic vesicle for storage and release
  • Increase in synthesis and release of dopamine, and inhibition of dopamine uptake.
  • Selective M1 muscarinic acetylcholine receptor antagonist. It is able to discriminate between the M1 (cortical or neuronal) and the peripheral muscarinic subtypes (cardiac and glandular)

Frage 45

Frage
Acute [blank_start]laryngeal[blank_end] dystonia is considered a medical emergency. Must seek treatment immediately. May require IV diphenhydramine
Antworten
  • laryngeal

Frage 46

Frage
Velbenazine is extensively metabolized by hydrolysis to form active metabolite and by oxidative metabolism to form mono-oxidized valbenazine and other minor metabolites
Antworten
  • True
  • False

Frage 47

Frage
High fat meals may [blank_start]decrease[blank_end] absorption of valbenazine (Ingrezza)
Antworten
  • decrease
  • increase

Frage 48

Frage
Common adverse side effects of valbenazine (Ingrezza) include:
Antworten
  • Fatigue
  • HA
  • Constipation
  • Diarrhea
  • UTI
  • Somnolence

Frage 49

Frage
Warnings for valbenazine (Ingrezza) include:
Antworten
  • Somnolence
  • QTc prolongation
  • Pregnancy/breastfeeding
  • Hypertension

Frage 50

Frage
Valbenazine should not be used in:
Antworten
  • Severe renal impairment (< 30 mL/min)
  • CHF
  • Cirrhosis
  • Pancreatitis

Frage 51

Frage
Strong 3A4/2D6 inhibitors: [blank_start]Increase[blank_end] valbenazine concentration Strong 3A4 inducer: [blank_start]Decrease[blank_end] valbenazine concentration
Antworten
  • Increase
  • Decrease
  • Increase
  • Decrease

Frage 52

Frage
Valbenazine (Ingrezza) interacts with MAOIs by [blank_start]increasing[blank_end] the monamine NT in the synapse
Antworten
  • increasing
  • decreasing

Frage 53

Frage
Valbenazine (Ingrezza) interacts with digoxin and [blank_start]increase[blank_end]s the digoxin concentration by p-glycoprotein [blank_start]inhibtion[blank_end]
Antworten
  • increase
  • decreases
  • inhibtion
  • inducer

Frage 54

Frage
Deutetrabenazine (Austedo) is used for the treatment of chorea and schizophrenia/schizoaffective disorder. It is metabolized by CYP2D6
Antworten
  • True
  • False
Zusammenfassung anzeigen Zusammenfassung ausblenden

ähnlicher Inhalt

Thromboseprophylaxe
tia.weber
Bourdieu
Melanie Najm
Zeiten Englisch
barbara91
Geometrie
Tahir Celikkol
LB F, Kapitel 2, Grundbegriffe der Kosten- und Leistungsrechnung
Stefan Kurtenbach
OEKO - Fragenkatalog 2
Sarah Rettätsfro
Klinische Psychologie Teil 2
Lisa Mariá Hchil
BIWI - Steop 2 Teil 1
Katja Hofschneider
Basiswissen_MS-4.2_Foliensatz I
Bernd Leisen
MS-4 Tutorium 25.11.-1.12.2019
Lukas Imwalle
Vetie Innere Medizin 2020
Ferdinand Kähn